Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules

This publication has 21 references indexed in Scilit:

• Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers
  Archives of Disease in Childhood, 2011
• Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life
  The Pediatric Infectious Disease Journal, 2010
• Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
  Proceedings of the National Academy of Sciences, 2010
• Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
  BMJ, 2010
• Epidemiological Profile of Meningococcal Disease in the United States
  Clinical Infectious Diseases, 2010
• Global epidemiology of meningococcal disease
  Vaccine, 2009
• Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
  Vaccine, 2009
• Meningococcal C conjugate vaccine: The experience in England and Wales
  Vaccine, 2009
• A universal vaccine for serogroup B meningococcus
  Proceedings of the National Academy of Sciences, 2006
• Interlaboratory Standardization of the Measurement of Serum Bactericidal Activity by Using Human Complement against Meningococcal Serogroup B, Strain 44/76-SL, before and after Vaccination with the Norwegian MenBvac Outer Membrane Vesicle Vaccine
  Clinical and Vaccine Immunology, 2005